Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
The Drug Delivery Systems (DDS) industry has gone through extensive changes in the last few decades due to its increasing role in driving patient care and outcomes. It has pushed players to develop new strategies that cover the dynamic needs of their biopharmaceutical customers.
Join our guest Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma, Aude Ouensanga, Partner at Alira Health, and our host Kenny Carberry, Associate Director of Clinical Development, Alira Health as they discuss the impact of COVID-19, the evolution of the industry and its future, and the relationship between DDS organizations and the pharma industry by sharing insights and experiences from the perspective of a multinational healthcare consulting firm, and a global manufacturer and supplier of consumer dispensing packaging and drug delivery services.
For recent insights on the Drug Delivery Devices industry, download our latest report
LISTEN TO THE EPISODE BELOW
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
The EU Pharmaceutical Package: Introduction to Changes
Alira Health Joins France Biotech as an Expert Partner
Webinar: How to Increase Patient Engagement in Your Clinical Trials
Introduction to Patient Engagement in MedTech in the U.S.
PSI 2023 Conference
World Orphan Drug Congress USA
Subscribe to our newsletter for the latest news, events, and thought leadership